Jingjing Deng Selected Research

Adenocarcinoma of Lung

10/2022	Exploration of a Novel Circadian miRNA Pair Signature for Predicting Prognosis of Lung Adenocarcinoma.
7/2022	Identification of Ubiquitin-Related Gene-Pair Signatures for Predicting Tumor Microenvironment Infiltration and Drug Sensitivity of Lung Adenocarcinoma.
2/2022	ERCC6L is a biomarker and therapeutic target for non-small cell lung adenocarcinoma.
1/2022	Identification of a novel gene signature of lung adenocarcinoma based on epidermal growth factor receptor-tyrosine kinase inhibitor resistance.
1/2021	Immune-Related lncRNA Pairs as Prognostic Signature and Immune-Landscape Predictor in Lung Adenocarcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jingjing Deng Research Topics

Disease

16	Neoplasms (Cancer) 12/2023 - 11/2012
5	Adenocarcinoma of Lung 10/2022 - 01/2021
5	Alzheimer Disease (Alzheimer's Disease) 11/2021 - 04/2019
5	Inflammation (Inflammations) 11/2019 - 04/2011
4	Lung Neoplasms (Lung Cancer) 07/2022 - 01/2021
3	Infections 01/2024 - 04/2011
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 08/2023 - 11/2019
3	Poisoning 01/2021 - 05/2017
2	Body Weight (Weight, Body) 08/2022 - 01/2021
2	Dehydration (Water Stress) 01/2021 - 06/2015
2	Pathologic Processes 10/2014 - 11/2012
1	Lymphoma (Lymphomas) 12/2023
1	Asthma (Bronchial Asthma) 12/2022
1	Periodontitis 01/2022
1	Chronic Periodontitis 01/2022
1	Plasma Cell Leukemia 01/2022
1	Multiple Myeloma 01/2022
1	Periodontal Pocket (Periodontal Pockets) 01/2022
1	Dementia (Dementias) 01/2021
1	Brain Diseases (Brain Disorder) 01/2021
1	Acoustic Neuroma (Acoustic Neurinoma) 01/2021
1	Neurofibromatosis 2 (Neurofibromatosis Type II) 01/2021
1	Neurilemmoma (Schwannoma) 01/2021
1	Pneumonia (Pneumonitis) 01/2021
1	Meningioma (Meningiomas) 01/2021
1	Anthrax 10/2020
1	Stomach Neoplasms (Stomach Cancer) 09/2020
1	Dental Caries (Decay, Dental) 08/2020

Drug/Important Bio-Agent (IBA)

9	Biomarkers (Surrogate Marker)IBA 07/2022 - 05/2017
3	MicroRNAs (MicroRNA)IBA 10/2022 - 01/2013
3	PolymersIBA 10/2020 - 09/2013
3	CytokinesIBA 01/2019 - 11/2012
3	GoldIBA 10/2014 - 02/2013
2	Proteins (Proteins, Gene)FDA Link 01/2024 - 11/2019
2	ErbB Receptors (EGF Receptor)IBA 09/2022 - 01/2022
2	Tyrosine Kinase InhibitorsIBA 09/2022 - 01/2022
2	AntibodiesIBA 05/2022 - 04/2019
2	Protein Isoforms (Isoforms)IBA 11/2021 - 09/2020
2	PesticidesIBA 01/2021 - 09/2020
2	AcetylcholinesteraseIBA 09/2020 - 05/2017
2	Amyloid (Amyloid Fibrils)IBA 08/2020 - 11/2019
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 05/2013 - 03/2011
2	Cysteine (L-Cysteine)FDA Link 02/2013 - 11/2012
2	Interferon-gamma (Interferon, gamma)IBA 01/2013 - 04/2011
2	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 11/2012 - 03/2011
1	Histone Deacetylases (Histone Deacetylase)IBA 12/2023
1	benzamideIBA 12/2023
1	RNA-Binding Proteins (RNA-Binding Protein)IBA 08/2023
1	Immunoglobulin E (IgE)IBA 12/2022
1	Omalizumab (Xolair)FDA Link 12/2022
1	GlucocorticoidsIBA 12/2022
1	anti-IgE antibodiesIBA 12/2022
1	Adrenal Cortex Hormones (Corticosteroids)IBA 12/2022
1	Monoclonal AntibodiesIBA 12/2022
1	Cancer VaccinesIBA 11/2022
1	Liposomes (Liposome)IBA 11/2022
1	Phospholipids (Phosphatides)FDA LinkGeneric 11/2022
1	VaccinesIBA 11/2022
1	Gefitinib (Iressa)FDA Link 09/2022
1	fasudil (AT 877)IBA 09/2022
1	AerosolsIBA 08/2022
1	SolventsIBA 08/2022
1	UbiquitinIBA 07/2022
1	Anti-Bacterial Agents (Antibiotics)IBA 07/2022
1	Neoplasm Antigens (Tumor Antigens)IBA 01/2022
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2022
1	Immune Checkpoint InhibitorsIBA 01/2022
1	Chimeric Antigen ReceptorsIBA 01/2022
1	LigandsIBA 01/2022
1	bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA 01/2022
1	Minocycline (Cyclops)FDA LinkGeneric 01/2022
1	Muramidase (Lysozyme)IBA 01/2022
1	Ointments (Pastes)IBA 01/2022
1	Prealbumin (Transthyretin)IBA 01/2021
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2021
1	antigen CYFRA21.1IBA 01/2021
1	Growth Differentiation Factor 15IBA 01/2021
1	Long Noncoding RNAIBA 01/2021
1	CeramidesIBA 01/2021
1	Carcinoembryonic AntigenIBA 01/2021
1	Hemoglobins (Hemoglobin)IBA 01/2021
1	polyporic acidIBA 01/2021
1	SphingolipidsIBA 01/2021
1	Everolimus FDA Link 01/2021
1	Phosphopyruvate Hydratase (Enolase)IBA 01/2021
1	Keratin-19 (Keratin 19)IBA 01/2021
1	Mechanistic Target of Rapamycin Complex 1IBA 01/2021
1	GelsolinIBA 11/2020
1	Indicators and Reagents (Reagents)IBA 11/2020
1	dipicolinic acidIBA 10/2020
1	Coffee FDA Link 10/2020
1	Protein AggregatesIBA 08/2020
1	Durapatite (Hydroxylapatite)IBA 08/2020
1	Lanthanoid Series Elements (Lanthanides)IBA 04/2020

Therapy/Procedure

9	Therapeutics 12/2022 - 02/2013
2	Drug Therapy (Chemotherapy) 01/2021 - 05/2013
1	Aftercare (After-Treatment) 12/2022
1	Immunotherapy 11/2022
1	Salvage Therapy 01/2022
1	Dental Scaling 01/2022